Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA microarray: A prospective validation study

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Zhang, Zehua ^a   Li, Litao ^b   Luo, Fei ^a   Cheng, Peng ^a   Wu, Feng ^a   Wu, Zheng ^a   Hou, Tianyong ^a   Zhong, Min ^c   Xu, Jianzhong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b 309TH HOSPITAL OF PLA   (China)

^c Department of Clinical Laboratory   (China)

Author keywords

DNA microarray; Drug resistance; Gene mutation; Spinal tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CHILD; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DNA MICROARRAY; FEASIBILITY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRESCHOOL CHILD; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUBERCULOUS SPONDYLITIS; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; ISONIAZID; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSPECTIVE STUDIES; RIFAMPIN; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, SPINAL; YOUNG ADULT;

EID: 84868700756     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-303     Document Type: Article

References (16)

1. World Health Organization Global tuberculosis control 2010 2010, Geneva: WHO, IOP Publishing PhysicsWeb. http://www.who.int/tb/publications/global_report/en/, World Health Organization.
2. Li L, Zhang Z, Jianzhong X. Management of drug-resistant spinal tuberculosis with a combination of surgery and individualized chemotherapy: a retrospective analysis of thirty-five patients. Int Orthop 2011, 36:277-283.
3. Rüsch S, Gaby E, Casal M. Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. J Clin Microbiol 2006, 44(3):688-692. 10.1128/JCM.44.3.688-692.2006, 1393114, 16517840.
4. Sun A, Fan X, An W, Yan J. Rapid Detection of rpoB Gene Mutations in Rif-resistant M.tuberculosis Isolates by Oligonucleotide Microarray. Biomed Environ Sci 2009, 22:253-258. 10.1016/S0895-3988(09)60053-2, 19725469.
5. Cabibbe AM, Miotto P, Lazzeri E, Mugasa J, Santoro F. New DNA microarray platform for detection of MDR Mycobacterium tuberculosis and of drug-resistant malaria. Clin Microbiol Infect 2011, 17(Suppl 3):591-592.
6. Yao C, Zhu T, Li Y, Zhang L, Zhang B, Huang J, Fu W. Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray. Clin Microbiol Infect 2010, 16(11):1639-1643. 10.1111/j.1469-0691.2010.03267.x, 20491829.
7. Catharina C, Boehme CC, Pamela N. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010, 363(11):1005-1015. 10.1056/NEJMoa0907847, 2947799, 20825313.
8. Boehme CC, Nicol MP, Nabeta P. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011, 377(9776):1495-1505. 10.1016/S0140-6736(11)60438-8, 3085933, 21507477.
9. Bazira J, Asiimwe BB, Joloba ML. Use of the GenoType® MTBDRplus assay to assess drug resistance of Mycobacterium tuberculosis isolates from patients in rural Uganda. BMC Clin Pathol 2010, 10:5. 10.1186/1472-6890-10-5, 2924299, 20691055.
10. Abebe G, Paasch F, Apers L. Tuberculosis drug resistance testing by molecular methods: Opportunities and challenges in resource limited settings. Journal of Microbiological Methods 2011, 84:155-160. 10.1016/j.mimet.2010.11.014, 21129417.
11. Guo Y, Zhou Y, Wang C, Cheng J. Rapid, accurate determination of multidrug resistance in M. tuberculosis isolates and sputum using a biochip system. Int J Tuberc Lung Dis 2009, 13(7):914-920.
12. Zhu L, Jiang G, Wang S, Guo Y. Biochip system for rapid and accurate identification of Mycobacterial species from isolates and sputum. J Clin Microbiol 2010, 48(10):3654-3660. 10.1128/JCM.00158-10, 2953089, 20686082.
13. The basis speciality committee on bas science of Chinese Anti-tuberculosis Association The laboratory science procedure of diagnostic bacteriology in tuberculosis. Chinese Journal of Anti-tuberculosis 1996, 18(1):28-31. The basis speciality committee on bas science of Chinese Anti-tuberculosis Association.
14. Lawn SD, Zumla AI. Diagnosis of extrapulmonary tuberculosis using the Xpert MTB/RIF assay. Expert Rev Anti Infect Ther 2012, 10(6):631-635. 10.1586/eri.12.43, 22734954.
15. Suzana S, Shalini B, Rupali P, et al. Rapid diagnosis of extra pulmonary tuberculosis by automated Xpert MTB/RIF assay. BMC Infect Dis 2012, 12(Suppl 1):P32.
16. Vadwai V, Boehme C, Nabeta P, et al. Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis. J Clin Microbiol 2011, 49(7):2540-2545. 10.1128/JCM.02319-10, 3147857, 21593262.